Skip to main content
Top
Published in: Journal of Neural Transmission 12/2015

01-12-2015 | Neurology and Preclinical Neurological Studies - Original Article

Quantitative assessment of non-motor fluctuations in Parkinson’s disease using the Non-Motor Symptoms Scale (NMSS)

Authors: Alexander Storch, Christine B. Schneider, Lisa Klingelhöfer, Per Odin, Gerd Fuchs, Wolfgang H. Jost, Pablo Martinez-Martin, Rainer Koch, Heinz Reichmann, K. Ray Chaudhuri, Georg Ebersbach, NoMoFlu-PD study group

Published in: Journal of Neural Transmission | Issue 12/2015

Login to get access

Abstract

Data on frequency, severity and correlations of NMS with motor complications are only available for a limited number of NMS. The NMS Scale (NMSS) is a validated tool to assess a broad range of NMS, which has not been used in NMS fluctuations. We assessed fluctuations of a broad range of non-motor symptom (NMS) for a 1-month time period in fluctuating Parkinson’s disease (PD) in a multicenter cross-sectional study using the NMSS assessing NMS in motor On (NMSSOn) and Off state (NMSSOff) combined with clinical NMS and motor function scoring in 100 fluctuating PD patients. ΔNMSSOn/Off was defined as the differences of NMSS scores between On and Off. Complete NMSS datasets were available from 73 patients (53 % men; age: 68.2 ± 9.7 years) with mean total NMSS score in On state of 41.5 ± 37.6 and in Off state of 75.6 ± 42.3 (P < 0.001). Scores were higher in Off compared to On state for all domains except for domain “perceptual problems/hallucinations” (P = 0.608). Clinimetric properties of the NMSS were similar to those reported previously for NMS assessments independent of motor oscillations. NMSSOn, NMSSOff and ΔNMSSOn/Off showed weak to moderate correlations with demographics, indicators of motor symptom severity as well as with other measures of NMS, depression and quality of life. Correlations of NMSS items/domains with independent measures of related constructs were weak to moderate. In conclusion, when assessed with the NMSS, a broad range of NMS fluctuate with motor oscillations, but these fluctuations do neither correlate with motor function nor with measures of disease progression.
Appendix
Available only for authorised users
Literature
go back to reference Bayulkem K, Lopez G (2011) Clinical approach to nonmotor sensory fluctuations in Parkinson’s disease. J Neurol Sci 310(1–2):82–85CrossRefPubMed Bayulkem K, Lopez G (2011) Clinical approach to nonmotor sensory fluctuations in Parkinson’s disease. J Neurol Sci 310(1–2):82–85CrossRefPubMed
go back to reference Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571CrossRefPubMed Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571CrossRefPubMed
go back to reference Calandrella D, Antonini A (2012) Pulsatile or continuous dopaminomimetic strategies in Parkinson’s disease. Parkinsonism Relat Disord 18(Suppl 1):S120–S122CrossRefPubMed Calandrella D, Antonini A (2012) Pulsatile or continuous dopaminomimetic strategies in Parkinson’s disease. Parkinsonism Relat Disord 18(Suppl 1):S120–S122CrossRefPubMed
go back to reference Chaudhuri KR, Martinez-Martin P, Schapira AH, Stocchi F, Sethi K, Odin P, Brown RG, Koller W, Barone P, MacPhee G, Kelly L, Rabey M, MacMahon D, Thomas S, Ondo W, Rye D, Forbes A, Tluk S, Dhawan V, Bowron A, Williams AJ, Olanow CW (2006) International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson’s disease: the NMSQuest study. Mov Disord 21(7):916–923CrossRefPubMed Chaudhuri KR, Martinez-Martin P, Schapira AH, Stocchi F, Sethi K, Odin P, Brown RG, Koller W, Barone P, MacPhee G, Kelly L, Rabey M, MacMahon D, Thomas S, Ondo W, Rye D, Forbes A, Tluk S, Dhawan V, Bowron A, Williams AJ, Olanow CW (2006) International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson’s disease: the NMSQuest study. Mov Disord 21(7):916–923CrossRefPubMed
go back to reference Chaudhuri KR, Martinez-Martin P, Brown RG, Sethi K, Stocchi F, Odin P, Ondo W, Abe K, Macphee G, Macmahon D, Barone P, Rabey M, Forbes A, Breen K, Tluk S, Naidu Y, Olanow W, Williams AJ, Thomas S, Rye D, Tsuboi Y, Hand A, Schapira AH (2007) The metric properties of a novel non-motor symptoms scale for Parkinson’s disease: results from an international pilot study. Mov Disord 22(13):1901–1911CrossRefPubMed Chaudhuri KR, Martinez-Martin P, Brown RG, Sethi K, Stocchi F, Odin P, Ondo W, Abe K, Macphee G, Macmahon D, Barone P, Rabey M, Forbes A, Breen K, Tluk S, Naidu Y, Olanow W, Williams AJ, Thomas S, Rye D, Tsuboi Y, Hand A, Schapira AH (2007) The metric properties of a novel non-motor symptoms scale for Parkinson’s disease: results from an international pilot study. Mov Disord 22(13):1901–1911CrossRefPubMed
go back to reference Chaudhuri KR, Rizos A, Sethi KD (2013a) Motor and nonmotor complications in Parkinson’s disease: an argument for continuous drug delivery? J Neural Transm 120(9):1305–1320PubMedCentralCrossRefPubMed Chaudhuri KR, Rizos A, Sethi KD (2013a) Motor and nonmotor complications in Parkinson’s disease: an argument for continuous drug delivery? J Neural Transm 120(9):1305–1320PubMedCentralCrossRefPubMed
go back to reference Chaudhuri KR, Rojo JM, Schapira AH, Brooks DJ, Stocchi F, Odin P, Antonini A, Brown RJ, Martinez-Martin P (2013b) A proposal for a comprehensive grading of Parkinson’s disease severity combining motor and non-motor assessments: meeting an unmet need. PLoS One 8(2):e57221CrossRef Chaudhuri KR, Rojo JM, Schapira AH, Brooks DJ, Stocchi F, Odin P, Antonini A, Brown RJ, Martinez-Martin P (2013b) A proposal for a comprehensive grading of Parkinson’s disease severity combining motor and non-motor assessments: meeting an unmet need. PLoS One 8(2):e57221CrossRef
go back to reference Cockrell JR, Folstein MF (1988) Mini-mental state examination (MMSE). Psychopharmacol Bull 24(4):689–692PubMed Cockrell JR, Folstein MF (1988) Mini-mental state examination (MMSE). Psychopharmacol Bull 24(4):689–692PubMed
go back to reference D’Amato RJ, Zweig RM, Whitehouse PJ, Wenk GL, Singer HS, Mayeux R, Price DL, Snyder SH (1987) Aminergic systems in Alzheimer’s disease and Parkinson’s disease. Ann Neurol 22(2):229–236CrossRefPubMed D’Amato RJ, Zweig RM, Whitehouse PJ, Wenk GL, Singer HS, Mayeux R, Price DL, Snyder SH (1987) Aminergic systems in Alzheimer’s disease and Parkinson’s disease. Ann Neurol 22(2):229–236CrossRefPubMed
go back to reference Dickson DW, Braak H, Duda JE, Duyckaerts C, Gasser T, Halliday GM, Hardy J, Leverenz JB, Del Tredici K, Wszolek ZK, Litvan I (2009) Neuropathological assessment of Parkinson’s disease: refining the diagnostic criteria. Lancet Neurol 8(12):1150–1157CrossRefPubMed Dickson DW, Braak H, Duda JE, Duyckaerts C, Gasser T, Halliday GM, Hardy J, Leverenz JB, Del Tredici K, Wszolek ZK, Litvan I (2009) Neuropathological assessment of Parkinson’s disease: refining the diagnostic criteria. Lancet Neurol 8(12):1150–1157CrossRefPubMed
go back to reference Fahn S, Elton RL, Committee UD (1987) The unified Parkinson’s disease rating scale. In: Fahn S, Marsden CD, Calne DB (eds) Recent developments in Parkinson’s disease., vol 2. Macmillan Healthcare Information, Florham Park, pp 153–163, 293–304 Fahn S, Elton RL, Committee UD (1987) The unified Parkinson’s disease rating scale. In: Fahn S, Marsden CD, Calne DB (eds) Recent developments in Parkinson’s disease., vol 2. Macmillan Healthcare Information, Florham Park, pp 153–163, 293–304
go back to reference Ferketich SL, Figueredo AJ, Knapp TR (1991) The multitrait-multimethod approach to construct validity. Res Nurs Health 14(4):315–320CrossRefPubMed Ferketich SL, Figueredo AJ, Knapp TR (1991) The multitrait-multimethod approach to construct validity. Res Nurs Health 14(4):315–320CrossRefPubMed
go back to reference Gallagher DA, Schrag A (2012) Psychosis, apathy, depression and anxiety in Parkinson’s disease. Neurobiol Disease 46(3):581–589CrossRef Gallagher DA, Schrag A (2012) Psychosis, apathy, depression and anxiety in Parkinson’s disease. Neurobiol Disease 46(3):581–589CrossRef
go back to reference Gallagher DA, Lees AJ, Schrag A (2010) What are the most important nonmotor symptoms in patients with Parkinson’s disease and are we missing them? Mov Disord 25(15):2493–2500CrossRefPubMed Gallagher DA, Lees AJ, Schrag A (2010) What are the most important nonmotor symptoms in patients with Parkinson’s disease and are we missing them? Mov Disord 25(15):2493–2500CrossRefPubMed
go back to reference Hillen ME, Sage JI (1996) Nonmotor fluctuations in patients with Parkinson’s disease. Neurology 47(5):1180–1183CrossRefPubMed Hillen ME, Sage JI (1996) Nonmotor fluctuations in patients with Parkinson’s disease. Neurology 47(5):1180–1183CrossRefPubMed
go back to reference Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55(3):181–184PubMedCentralCrossRefPubMed Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55(3):181–184PubMedCentralCrossRefPubMed
go back to reference Kulisevsky J, Pascual-Sedano B, Barbanoj M, Gironell A, Pagonabarraga J, Garcia-Sanchez C (2007) Acute effects of immediate and controlled-release levodopa on mood in Parkinson’s disease: a double-blind study. Mov Disord 22(1):62–67CrossRefPubMed Kulisevsky J, Pascual-Sedano B, Barbanoj M, Gironell A, Pagonabarraga J, Garcia-Sanchez C (2007) Acute effects of immediate and controlled-release levodopa on mood in Parkinson’s disease: a double-blind study. Mov Disord 22(1):62–67CrossRefPubMed
go back to reference Kuopio AM, Marttila RJ, Helenius H, Toivonen M, Rinne UK (2000) The quality of life in Parkinson’s disease. Mov Disord 15(2):216–223CrossRefPubMed Kuopio AM, Marttila RJ, Helenius H, Toivonen M, Rinne UK (2000) The quality of life in Parkinson’s disease. Mov Disord 15(2):216–223CrossRefPubMed
go back to reference Martinez-Martin P, Rodriguez-Blazquez C, Abe K, Bhattacharyya KB, Bloem BR, Carod-Artal FJ, Prakash R, Esselink RA, Falup-Pecurariu C, Gallardo M, Mir P, Naidu Y, Nicoletti A, Sethi K, Tsuboi Y, van Hilten JJ, Visser M, Zappia M, Chaudhuri KR (2009) International study on the psychometric attributes of the non-motor symptoms scale in Parkinson disease. Neurology 73(19):1584–1591CrossRefPubMed Martinez-Martin P, Rodriguez-Blazquez C, Abe K, Bhattacharyya KB, Bloem BR, Carod-Artal FJ, Prakash R, Esselink RA, Falup-Pecurariu C, Gallardo M, Mir P, Naidu Y, Nicoletti A, Sethi K, Tsuboi Y, van Hilten JJ, Visser M, Zappia M, Chaudhuri KR (2009) International study on the psychometric attributes of the non-motor symptoms scale in Parkinson disease. Neurology 73(19):1584–1591CrossRefPubMed
go back to reference Martinez-Martin P, Rodriguez-Blazquez C, Kurtis MM, Chaudhuri KR (2011) The impact of non-motor symptoms on health-related quality of life of patients with Parkinson’s disease. Mov Disord 26(3):399–406CrossRefPubMed Martinez-Martin P, Rodriguez-Blazquez C, Kurtis MM, Chaudhuri KR (2011) The impact of non-motor symptoms on health-related quality of life of patients with Parkinson’s disease. Mov Disord 26(3):399–406CrossRefPubMed
go back to reference McHorney CA, Tarlov AR (1995) Individual-patient monitoring in clinical practice: are available health status surveys adequate? Qual Life Res 4(4):293–307CrossRefPubMed McHorney CA, Tarlov AR (1995) Individual-patient monitoring in clinical practice: are available health status surveys adequate? Qual Life Res 4(4):293–307CrossRefPubMed
go back to reference Muller CM, de Vos RA, Maurage CA, Thal DR, Tolnay M, Braak H (2005) Staging of sporadic Parkinson disease-related alpha-synuclein pathology: inter- and intra-rater reliability. J Neuropathol Exp Neurol 64(7):623–628CrossRefPubMed Muller CM, de Vos RA, Maurage CA, Thal DR, Tolnay M, Braak H (2005) Staging of sporadic Parkinson disease-related alpha-synuclein pathology: inter- and intra-rater reliability. J Neuropathol Exp Neurol 64(7):623–628CrossRefPubMed
go back to reference Nebe A, Ebersbach G (2009) Pain intensity on and off levodopa in patients with Parkinson’s disease. Mov Disord 24(8):1233–1237CrossRefPubMed Nebe A, Ebersbach G (2009) Pain intensity on and off levodopa in patients with Parkinson’s disease. Mov Disord 24(8):1233–1237CrossRefPubMed
go back to reference Peto V, Jenkinson C, Fitzpatrick R, Greenhall R (1995) The development and validation of a short measure of functioning and well being for individuals with Parkinson’s disease. Qual Life Res 4(3):241–248CrossRefPubMed Peto V, Jenkinson C, Fitzpatrick R, Greenhall R (1995) The development and validation of a short measure of functioning and well being for individuals with Parkinson’s disease. Qual Life Res 4(3):241–248CrossRefPubMed
go back to reference Saper CB, Sorrentino DM, German DC, de Lacalle S (1991) Medullary catecholaminergic neurons in the normal human brain and in Parkinson’s disease. Ann Neurol 29(6):577–584CrossRefPubMed Saper CB, Sorrentino DM, German DC, de Lacalle S (1991) Medullary catecholaminergic neurons in the normal human brain and in Parkinson’s disease. Ann Neurol 29(6):577–584CrossRefPubMed
go back to reference Schrag A, Jahanshahi M, Quinn N (2000) What contributes to quality of life in patients with Parkinson’s disease? J Neurol Neurosurg Psychiatry 69(3):308–312PubMedCentralCrossRefPubMed Schrag A, Jahanshahi M, Quinn N (2000) What contributes to quality of life in patients with Parkinson’s disease? J Neurol Neurosurg Psychiatry 69(3):308–312PubMedCentralCrossRefPubMed
go back to reference Seki M, Takahashi K, Uematsu D, Mihara B, Morita Y, Isozumi K, Ohta K, Muramatsu K, Shirai T, Nogawa S, Gotoh J, Yamaguchi K, Tomita Y, Yasutomi D, Nihei Y, Iwasawa S, Suzuki N (2013) Clinical features and varieties of non-motor fluctuations in Parkinson’s disease: a Japanese multicenter study. Parkinsonism Relat Disord 19(1):104–108CrossRefPubMed Seki M, Takahashi K, Uematsu D, Mihara B, Morita Y, Isozumi K, Ohta K, Muramatsu K, Shirai T, Nogawa S, Gotoh J, Yamaguchi K, Tomita Y, Yasutomi D, Nihei Y, Iwasawa S, Suzuki N (2013) Clinical features and varieties of non-motor fluctuations in Parkinson’s disease: a Japanese multicenter study. Parkinsonism Relat Disord 19(1):104–108CrossRefPubMed
go back to reference Siemers ER, Shekhar A, Quaid K, Dickson H (1993) Anxiety and motor performance in Parkinson’s disease. Mov Disord 8(4):501–506CrossRefPubMed Siemers ER, Shekhar A, Quaid K, Dickson H (1993) Anxiety and motor performance in Parkinson’s disease. Mov Disord 8(4):501–506CrossRefPubMed
go back to reference Stacy MA, Murphy JM, Greeley DR, Stewart RM, Murck H, Meng X (2008) The sensitivity and specificity of the 9-item wearing-off questionnaire. Parkinsonism Relat Disord 14(3):205–212CrossRefPubMed Stacy MA, Murphy JM, Greeley DR, Stewart RM, Murck H, Meng X (2008) The sensitivity and specificity of the 9-item wearing-off questionnaire. Parkinsonism Relat Disord 14(3):205–212CrossRefPubMed
go back to reference Storch A, Odin P, Trender-Gerhard I, Fuchs G, Reifschneider G, Chaudhuri KR, Jost WH, Ebersbach G (2010) Non-motor Symptoms Questionnaire and Scale for Parkinson’s disease. Cross-cultural adaptation into the German language. Der Nervenarzt 81(8):980–985CrossRefPubMed Storch A, Odin P, Trender-Gerhard I, Fuchs G, Reifschneider G, Chaudhuri KR, Jost WH, Ebersbach G (2010) Non-motor Symptoms Questionnaire and Scale for Parkinson’s disease. Cross-cultural adaptation into the German language. Der Nervenarzt 81(8):980–985CrossRefPubMed
go back to reference Storch A, Schneider CB, Wolz M, Sturwald Y, Nebe A, Odin P, Mahler A, Fuchs G, Jost WH, Chaudhuri KR, Koch R, Reichmann H, Ebersbach G (2013) Nonmotor fluctuations in Parkinson disease: severity and correlation with motor complications. Neurology 80(9):800–809CrossRefPubMed Storch A, Schneider CB, Wolz M, Sturwald Y, Nebe A, Odin P, Mahler A, Fuchs G, Jost WH, Chaudhuri KR, Koch R, Reichmann H, Ebersbach G (2013) Nonmotor fluctuations in Parkinson disease: severity and correlation with motor complications. Neurology 80(9):800–809CrossRefPubMed
go back to reference Witjas T, Kaphan E, Azulay JP, Blin O, Ceccaldi M, Pouget J, Poncet M, Cherif AA (2002) Nonmotor fluctuations in Parkinson’s disease: frequent and disabling. Neurology 59(3):408–413CrossRefPubMed Witjas T, Kaphan E, Azulay JP, Blin O, Ceccaldi M, Pouget J, Poncet M, Cherif AA (2002) Nonmotor fluctuations in Parkinson’s disease: frequent and disabling. Neurology 59(3):408–413CrossRefPubMed
go back to reference Wolz M, Hauschild J, Fauser M, Klingelhofer L, Reichmann H, Storch A (2012) Immediate effects of deep brain stimulation of the subthalamic nucleus on nonmotor symptoms in Parkinson’s disease. Parkinsonism Relat Disord 18:994–997CrossRefPubMed Wolz M, Hauschild J, Fauser M, Klingelhofer L, Reichmann H, Storch A (2012) Immediate effects of deep brain stimulation of the subthalamic nucleus on nonmotor symptoms in Parkinson’s disease. Parkinsonism Relat Disord 18:994–997CrossRefPubMed
Metadata
Title
Quantitative assessment of non-motor fluctuations in Parkinson’s disease using the Non-Motor Symptoms Scale (NMSS)
Authors
Alexander Storch
Christine B. Schneider
Lisa Klingelhöfer
Per Odin
Gerd Fuchs
Wolfgang H. Jost
Pablo Martinez-Martin
Rainer Koch
Heinz Reichmann
K. Ray Chaudhuri
Georg Ebersbach
NoMoFlu-PD study group
Publication date
01-12-2015
Publisher
Springer Vienna
Published in
Journal of Neural Transmission / Issue 12/2015
Print ISSN: 0300-9564
Electronic ISSN: 1435-1463
DOI
https://doi.org/10.1007/s00702-015-1437-x

Other articles of this Issue 12/2015

Journal of Neural Transmission 12/2015 Go to the issue

Neurology and Preclinical Neurological Studies - Short communication

Small intestine dysfunction in Parkinson’s disease

Neurology and Preclinical Neurological Studies - Original Article

Generalized motor inhibitory deficit in Parkinson’s disease patients who freeze